These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5392877)

  • 1. Studies on tetanus toxin and toxoid. IV. Interaction of formaldehyde with tetanus toxin.
    Dawson DJ; Mauritzen CM
    Aust J Biol Sci; 1969 Oct; 22(5):1217-27. PubMed ID: 5392877
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of purified tetanus toxin and toxoid.
    Raynaud M; Turpin A; Bizzini B
    Prog Immunobiol Stand; 1967; 3():244-7. PubMed ID: 4985511
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of the detoxification mechanism of formaldehyde-treated tetanus toxin.
    Thaysen-Andersen M; Jørgensen SB; Wilhelmsen ES; Petersen JW; Højrup P
    Vaccine; 2007 Mar; 25(12):2213-27. PubMed ID: 17240009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on tetanus toxin and toxoid. I. Isolation of tetanus toxin using DEAE-cellulose.
    Dawson DJ; Mauritzen CM
    Aust J Biol Sci; 1967 Feb; 20(1):253-63. PubMed ID: 6034346
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of solid-phase gangliosides with tetanus toxin and toxoid.
    Habermann E; Tayot JL
    Toxicon; 1985; 23(6):913-20. PubMed ID: 4095706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the immunotherapy of tetanus. I. Purification and characterization of tetanus toxin.
    Dowdle EB; Koper G; Schaafsma AW
    S Afr J Med Sci; 1970 Dec; 35(3):75-80. PubMed ID: 4938392
    [No Abstract]   [Full Text] [Related]  

  • 7. An effective toxoid from tetanus toxin prepared by stepwise iodination of purified toxin.
    Soares HR; Nunes RL; Prado SM; Higashi HG; Heneine IF
    Biologicals; 1994 Mar; 22(1):29-33. PubMed ID: 8068311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on tetanus toxin and toxoid. 3. Sedimentation of toxin and derivatives obtained by sulphite and aldehyde treatments.
    Dawson DJ; Nichol LW
    Aust J Biol Sci; 1969 Feb; 22(1):247-55. PubMed ID: 4891122
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activation of transcortin binding ability during the interaction of liver and plasma proteins].
    Rozen VB; Zavadskiĭ PS
    Vopr Med Khim; 1969; 15(4):425-31. PubMed ID: 4187159
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemical assay of tetanus toxin and toxoid. II. N- and C-terminal amino acids].
    Klimek J
    Med Dosw Mikrobiol; 1969; 21(4):373-7. PubMed ID: 5371512
    [No Abstract]   [Full Text] [Related]  

  • 11. THE INCORPORATION OF C 14-LABELED GLUCOSE AND LEUCINE INTO THE BRAIN PROTEINS OF WHITE MICE INJECTED WITH TETANUS TOXIN.
    KLOETZEL K
    J Infect Dis; 1964 Apr; 114():157-62. PubMed ID: 14141857
    [No Abstract]   [Full Text] [Related]  

  • 12. The combined use of analytical tools for exploring tetanus toxin and tetanus toxoid structures.
    Bayart C; Peronin S; Jean E; Paladino J; Talaga P; Borgne ML
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1054():80-92. PubMed ID: 28448854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetanus toxin.
    van Heyningen S
    Pharmacol Ther; 1980; 11(1):141-57. PubMed ID: 7001499
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA; Sviridov VV; Perelygina OV
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual enzymatic activity of the tetanus toxin light chain present in tetanus toxoid batches used for vaccine production.
    Behrensdorf-Nicol HA; Kegel B; Bonifas U; Silberbach K; Klimek J; Weiber K; Krämer B
    Vaccine; 2008 Jul; 26(31):3835-41. PubMed ID: 18554757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical characterization of tetanus toxin and toxoid. Amino acid composition, number of SH and S-S groups and N-terminal amino acid.
    Bizzini B; Blass J; Turpin A; Raynaud M
    Eur J Biochem; 1970 Nov; 17(1):100-5. PubMed ID: 5486573
    [No Abstract]   [Full Text] [Related]  

  • 17. Localized tetanus in immunized mice.
    Fishman PS; Parks DA; Bowen T; Matthews CC
    Neurotoxicology; 2009 Jul; 30(4):697-701. PubMed ID: 19465055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic and immunogenic studies on purified tetanus toxoid.
    Nielsen PA; Ablondi FB; Querry MV; Gussoni C; Cooper MS
    J Immunol; 1967 Jun; 98(6):1248-56. PubMed ID: 4961126
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
    Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N
    Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of tetanus toxin with selective chemical reagents.
    Stein P; Biel H
    Z Immunitatsforsch Exp Klin Immunol; 1973 Sep; 145(5):418-31. PubMed ID: 4282960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.